Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to Friday's FDA submission, they have already started “rolling” applications in Europe and the U.K. and intend to submit similar information soon.

With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.

“Help is on the way,” Dr. Anthony Fauci, the top U.S. infectious disease expert said on the eve of Pfizer's announcement, adding that it's too early to abandon masks and other protective measures. “We need to actually double down on the public health measures as we're waiting for that help to come.”

Friday’s filing sets off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.

How much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed. About 25 million doses of the Pfizer vaccine may become available in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart.

Not far behind is competitor Moderna Inc.’s COVID-19 vaccine. Its early data suggests the shots are as strong as Pfizer’s, and that company expects to also seek emergency authorization within weeks.

The public’s first chance to see how strong the evidence really is will come in early December at a public meeting of the FDA’s scientific advisers.

So far, what's known is based only on statements from Pfizer and BioNTech. Of 170 infections detected to date, only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. On the safety side, the companies cites results from 38,000 study participants who've been tracked for two months after their second dose. That's a milestone FDA set because historically, vaccine side effects don't crop up later than that.

“We’ll drill down on these data,” said FDA adviser Dr. Paul Offit of the Children’s Hospital of Philadelphia.

Think of it like science on trial. A few days before the meeting, the FDA will release its own internal analysis. That sets the stage for the advisers’ daylong debate about any signs of safety concerns and how the new vaccine technology works before rendering a verdict.

They’ll recommend not just whether FDA should allow broader use of the vaccine generally but if so, for whom. For example, is there enough proof the vaccine works as well for older, sicker adults as for younger, healthier people?

There’s still no guarantee. “We don’t know what that vote’s going to be,” said former FDA vaccine chief Norman Baylor.

EMERGENCY USE ISN’T THE SAME AS FULL APPROVAL

If there's an emergency green light, “that vaccine is still deemed investigational. It’s not approved yet,” Dr. Marion Gruber, chief of FDA’s vaccine office, told the National Academy of Medicine this week.

That means anyone offered an emergency vaccination must get a “fact sheet” describing potential benefits and risks before going through with the shot, she said.

There will be a lot of unknowns. For example, the 95% protection rate is based on people who developed symptoms and then were tested for the virus. Can the vaccinated get infected but have no symptoms, able to spread the virus? How long does protection last?

That’s why the 44,000-person study needs to keep running -- something difficult considering ethically, participants given dummy shots at some point must be offered real vaccine, complicating the search for answers.

And at least for now, pregnant women won't qualify because they weren't studied. Pfizer only recently began testing the vaccine in children as young as 12.

A decision on Pfizer's vaccine won't affect other COVID-19 vaccine candidates in the pipeline, which will be judged separately.

Brewing vaccine is more complex than typical drug manufacturing, yet the millionth dose to roll out of Pfizer’s Kalamazoo, Michigan, factory must be the same purity and potency as every dose before and after.

That means the FDA decision isn’t just based on study data, but on its determination that the vaccine is being made correctly.

The Pfizer-BioNTech vaccine -- and Moderna's shots -- are made with brand-new technology. They don’t contain the actual coronavirus. Instead, they’re made with a piece of genetic code for the “spike” protein that studs the virus.

That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

Another government group -- advisers to the Centers for Disease Control and Prevention -- decides who is first in line for scarce doses. Health and Human Services Secretary Alex Azar said he hopes that decision can be made at the same time as FDA’s.

The Trump administration’s Operation Warp Speed has worked with states to line up how many doses they’d need to cover the populations offered vaccine first.

Pfizer will ship those supplies as ordered by the states -- only after FDA gives the OK.

Company projections of how much it will ship each month are just predictions, Baylor warned.

“It’s not like a pizza,” he said. Manufacturing is so complex that “you don’t necessarily end up with what you thought.”

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1604926559777.png" alt="Photo courtesy Pfizer" />
 <figcaption>Photo courtesy Pfizer</figcaption>
 </figure>BY LAURAN NEERGAARD, AP Medical WriterPfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to Friday's FDA submission, they have already started “rolling” applications in Europe and the U.K. and intend to submit similar information soon.With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.“Help is on the way,” Dr. Anthony Fauci, the top U.S. infectious disease expert said on the eve of Pfizer's announcement, adding that it's too early to abandon masks and other protective measures. “We need to actually double down on the public health measures as we're waiting for that help to come.”Friday’s filing sets off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.How much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed. About 25 million doses of the Pfizer vaccine may become available in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart.Not far behind is competitor Moderna Inc.’s COVID-19 vaccine. Its early data suggests the shots are as strong as Pfizer’s, and that company expects to also seek emergency authorization within weeks.Here’s what happens next:MAKING THE DATA PUBLICThe public’s first chance to see how strong the evidence really is will come in early December at a public meeting of the FDA’s scientific advisers.So far, what's known is based only on statements from Pfizer and BioNTech. Of 170 infections detected to date, only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. On the safety side, the companies cites results from 38,000 study participants who've been tracked for two months after their second dose. That's a milestone FDA set because historically, vaccine side effects don't crop up later than that.“We’ll drill down on these data,” said FDA adviser Dr. Paul Offit of the Children’s Hospital of Philadelphia.Think of it like science on trial. A few days before the meeting, the FDA will release its own internal analysis. That sets the stage for the advisers’ daylong debate about any signs of safety concerns and how the new vaccine technology works before rendering a verdict.They’ll recommend not just whether FDA should allow broader use of the vaccine generally but if so, for whom. For example, is there enough proof the vaccine works as well for older, sicker adults as for younger, healthier people?There’s still no guarantee. “We don’t know what that vote’s going to be,” said former FDA vaccine chief Norman Baylor.EMERGENCY USE ISN’T THE SAME AS FULL APPROVALIf there's an emergency green light, “that vaccine is still deemed investigational. It’s not approved yet,” Dr. Marion Gruber, chief of FDA’s vaccine office, told the National Academy of Medicine this week.That means anyone offered an emergency vaccination must get a “fact sheet” describing potential benefits and risks before going through with the shot, she said.There will be a lot of unknowns. For example, the 95% protection rate is based on people who developed symptoms and then were tested for the virus. Can the vaccinated get infected but have no symptoms, able to spread the virus? How long does protection last?That’s why the 44,000-person study needs to keep running -- something difficult considering ethically, participants given dummy shots at some point must be offered real vaccine, complicating the search for answers.And at least for now, pregnant women won't qualify because they weren't studied. Pfizer only recently began testing the vaccine in children as young as 12.A decision on Pfizer's vaccine won't affect other COVID-19 vaccine candidates in the pipeline, which will be judged separately.MANUFACTURINGBrewing vaccine is more complex than typical drug manufacturing, yet the millionth dose to roll out of Pfizer’s Kalamazoo, Michigan, factory must be the same purity and potency as every dose before and after.That means the FDA decision isn’t just based on study data, but on its determination that the vaccine is being made correctly.The Pfizer-BioNTech vaccine -- and Moderna's shots -- are made with brand-new technology. They don’t contain the actual coronavirus. Instead, they’re made with a piece of genetic code for the “spike” protein that studs the virus.That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.GETTING INTO PEOPLE’S ARMSAnother government group -- advisers to the Centers for Disease Control and Prevention -- decides who is first in line for scarce doses. Health and Human Services Secretary Alex Azar said he hopes that decision can be made at the same time as FDA’s.The Trump administration’s Operation Warp Speed has worked with states to line up how many doses they’d need to cover the populations offered vaccine first.Pfizer will ship those supplies as ordered by the states -- only after FDA gives the OK.Company projections of how much it will ship each month are just predictions, Baylor warned.“It’s not like a pizza,” he said. Manufacturing is so complex that “you don’t necessarily end up with what you thought.”___

Pfizer seeking emergency use of its COVID-19 vaccine in US

By&nbsp;<a href="https://news.unl.edu/written-by/leslie-reed-university-communication/">Leslie Reed | University Communication</a>

In a joint effort, University Operations and University Housing are preparing up to 45 rooms in Harper Hall to be available under a state government contract to provide self-quarantine space for first responders, health care workers and&nbsp;others.

To allow for proper social distancing, no more than five rooms on each of nine residential floors of the hall will be assigned to people who need out-of-home quarantine housing because they or someone they live with has been exposed to&nbsp;COVID-19.

The University of Nebraska system signed a contract with the State of Nebraska in early April to supply beds for quarantine purposes at University of Nebraska–Lincoln, University of Nebraska at Omaha, University of Nebraska at Kearney and Nebraska College of Technical Agriculture at&nbsp;Curtis.

Gov. Pete Ricketts announced the launch of the program during his&nbsp;COVID-19 briefing April 17 at the State Capitol. He said the first people seeking quarantine space would arrive at&nbsp;UNO&nbsp;facilities soon. It is not known when Harper Hall rooms might be brought into&nbsp;use.

According to Jim Jackson, associate vice chancellor of University Operations, Harper Hall will be used to house people who do not have&nbsp;COVID-19 symptoms, but need to self-quarantine because of possible exposure to the coronavirus. Harper Hall is a traditional college residence hall, with communal restrooms on each&nbsp;floor.

Each room in use for quarantine will be assigned to a different set of fixtures in the restroom, so that those in quarantine will not share toilets, sinks or&nbsp;showers.

If isolation space is needed for people who have developed symptoms, they will be placed in suite-style housing on East Campus. Suite-style housing has bathroom facilities in each suite. In addition, if more self-quarantine space is needed for asymptomatic people, a second traditional residence hall on City Campus may be opened under operations similar to those planned for Harper&nbsp;Hall.

The Nebraska National Guard will be responsible for operation, security and maintenance of the facility while it is used for quarantine purposes. The university has hired an outside firm, Advance Services, Inc., to provide custodial services, with personnel being trained to follow&nbsp;CDC&nbsp;and other public health care protocols for&nbsp;COVID-19 cleaning and&nbsp;disinfecting.

University Dining Service will deliver three meals a day to the building, with offerings to include hot meals, vegetarian and special needs options. The meals will be distributed to individual rooms by the National&nbsp;Guard.

Jackson said the decision to hire an outside custodial firm was based upon an abundance of caution to separate the university community from the outside community. Housing staff continues to serve approximately 750 students who have been moved to suite-style housing on another part of the City Campus. The separation will reduce opportunities for coronavirus to be transmitted to university students or&nbsp;staff.

By&nbsp;<a href="https://news.unl.edu/written-by/leslie-reed-university-communication/">Leslie Reed | University Communication</a>In a joint effort, University Operations and University Housing are preparing up to 45 rooms in Harper Hall to be available under a state government contract to provide self-quarantine space for first responders, health care workers and&nbsp;others.To allow for proper social distancing, no more than five rooms on each of nine residential floors of the hall will be assigned to people who need out-of-home quarantine housing because they or someone they live with has been exposed to&nbsp;COVID-19.The University of Nebraska system signed a contract with the State of Nebraska in early April to supply beds for quarantine purposes at University of Nebraska–Lincoln, University of Nebraska at Omaha, University of Nebraska at Kearney and Nebraska College of Technical Agriculture at&nbsp;Curtis.Gov. Pete Ricketts announced the launch of the program during his&nbsp;COVID-19 briefing April 17 at the State Capitol. He said the first people seeking quarantine space would arrive at&nbsp;UNO&nbsp;facilities soon. It is not known when Harper Hall rooms might be brought into&nbsp;use.<figure>
 <img src="https://news.unl.edu/sites/default/files/styles/meta/public/media/200410_Harper_332a.jpg?itok=Z8idnvf2" alt="Craig Chandler | University CommunicationHarper Hall could be used to house first responders and medical personnel who need to self-isolate while still working. The Nebraska National Guard would supervise the hall. (Craig Chandler/University Communication)" />
 <figcaption>Craig Chandler | University CommunicationHarper Hall could be used to house first responders and medical personnel who need to self-isolate while still working. The Nebraska National Guard would supervise the hall. (Craig Chandler/University Communication)</figcaption>
 </figure>According to Jim Jackson, associate vice chancellor of University Operations, Harper Hall will be used to house people who do not have&nbsp;COVID-19 symptoms, but need to self-quarantine because of possible exposure to the coronavirus. Harper Hall is a traditional college residence hall, with communal restrooms on each&nbsp;floor.Each room in use for quarantine will be assigned to a different set of fixtures in the restroom, so that those in quarantine will not share toilets, sinks or&nbsp;showers.If isolation space is needed for people who have developed symptoms, they will be placed in suite-style housing on East Campus. Suite-style housing has bathroom facilities in each suite. In addition, if more self-quarantine space is needed for asymptomatic people, a second traditional residence hall on City Campus may be opened under operations similar to those planned for Harper&nbsp;Hall.The Nebraska National Guard will be responsible for operation, security and maintenance of the facility while it is used for quarantine purposes. The university has hired an outside firm, Advance Services, Inc., to provide custodial services, with personnel being trained to follow&nbsp;CDC&nbsp;and other public health care protocols for&nbsp;COVID-19 cleaning and&nbsp;disinfecting.University Dining Service will deliver three meals a day to the building, with offerings to include hot meals, vegetarian and special needs options. The meals will be distributed to individual rooms by the National&nbsp;Guard.Jackson said the decision to hire an outside custodial firm was based upon an abundance of caution to separate the university community from the outside community. Housing staff continues to serve approximately 750 students who have been moved to suite-style housing on another part of the City Campus. The separation will reduce opportunities for coronavirus to be transmitted to university students or&nbsp;staff.

UNL prepared to provide quarantine space for community

LINCOLN, Neb.-The Office of Governor Pete Ricketts announced that the State Capitol will be illuminated in blue light for Public Health Thank You Day. &nbsp;Monday, November 23, 2020, is the national observance. &nbsp;

“Nebraska’s public health officials and healthcare workers continue to show heroic grit and determination in the face of the ongoing pandemic,” said Governor Ricketts. &nbsp;“On Monday, I encourage everyone to join together and light a blue light to show their support for those who play a critical role in the health of Nebraskans.”&nbsp;

The Nebraska State Capitol will be lit in blue, and Nebraskans are encouraged to light their businesses, porches, and/or windows up in blue light to recognize our heroes.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605840265856.png" alt="" />
 <figcaption></figcaption>
 </figure>LINCOLN, Neb.-The Office of Governor Pete Ricketts announced that the State Capitol will be illuminated in blue light for Public Health Thank You Day. &nbsp;Monday, November 23, 2020, is the national observance. &nbsp;“Nebraska’s public health officials and healthcare workers continue to show heroic grit and determination in the face of the ongoing pandemic,” said Governor Ricketts. &nbsp;“On Monday, I encourage everyone to join together and light a blue light to show their support for those who play a critical role in the health of Nebraskans.”&nbsp;The Nebraska State Capitol will be lit in blue, and Nebraskans are encouraged to light their businesses, porches, and/or windows up in blue light to recognize our heroes.

Nebraska Capitol building to be lit blue for 'Public Health Thank You Day'

NORTH PLATTE, Neb. (WCDHD)-The risk dial moved from a 3.65 up to a 3.77 this week, which remains
in the severe risk level. There were changes in the following
variables that contributed to movement in the dial:

The COVID-19 Risk Dial contains
recommended guidance to help prevent and control the spread of
COVID-19.

While in the Severe Risk category,
physical distance of 6 feet or greater, wearing face coverings when
outside the home, frequent handwashing (or use of hand sanitizer),
staying home if you are having flu-like or COVID-like symptoms,
disinfecting high touch surfaces, and having at-risk and vulnerable
people remain home are recommended as the greatest tools in reducing
the spread of COVID-19. For more information on recommendations for
the various risk categories of the WCDHD Community Risk Dial, please
visit the COVID-19 Risk Dial page on our <a href="https://wcdhd.org/">website</a>.

View the Community Risk Dial page <a href="https://wcdhd.org/coronavirus/risk-dial.html">HERE</a>

View the WCDHD COVID-19 Dashboard <a href="https://public.tableau.com/profile/sydney.keller5172#!/vizhome/WestCentralDistrictHealthDepartmentCOVID-19Dashboard/CaseInformation">HERE</a>

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605840094701.png" alt="As of November 19, 2020" />
 <figcaption>As of November 19, 2020</figcaption>
 </figure>NORTH PLATTE, Neb. (WCDHD)-The risk dial moved from a 3.65 up to a 3.77 this week, which remains
in the severe risk level. There were changes in the following
variables that contributed to movement in the dial:We had an increase in the following:<ul>
 <li>Measure ID R5: ICU Availability
	</li><li>Measure ID R6: Ventilator
	Availability
	</li><li>Measure ID R9: Testing Turnaround
	Time
</li>
 </ul>The COVID-19 Risk Dial contains
recommended guidance to help prevent and control the spread of
COVID-19.While in the Severe Risk category,
physical distance of 6 feet or greater, wearing face coverings when
outside the home, frequent handwashing (or use of hand sanitizer),
staying home if you are having flu-like or COVID-like symptoms,
disinfecting high touch surfaces, and having at-risk and vulnerable
people remain home are recommended as the greatest tools in reducing
the spread of COVID-19. For more information on recommendations for
the various risk categories of the WCDHD Community Risk Dial, please
visit the COVID-19 Risk Dial page on our <a href="https://wcdhd.org/">website</a>.View the Community Risk Dial page <a href="https://wcdhd.org/coronavirus/risk-dial.html">HERE</a>View the WCDHD COVID-19 Dashboard <a href="https://public.tableau.com/profile/sydney.keller5172#!/vizhome/WestCentralDistrictHealthDepartmentCOVID-19Dashboard/CaseInformation">HERE</a>

WCDHD moves community risk dial up in Red level

Our state public education system is facing a crisis of historic proportion due to an unprecedented surge of COVID-19.

Between November 7 and November 13, on average, 124 patients with confirmed COVID-19 and 38 patients with suspected COVID-19 were reported as newly admitted each day to hospitals in Nebraska.&nbsp; On November 17, the White House Coronavirus Task Force issued a report indicating Nebraska has 101 or more new cases per 100,000 population, which is the sixth-highest infection rate in the country.&nbsp; Nebraska is also in the red zone for test positivity, indicating a rate at or above 10.1 percent, with the fourth-highest rate in the country.&nbsp; Nebraska had 735 new cases per 100,000 population, compared to a national average of 294 per 100,000.

The uncontrolled transmission of the virus has put the Nebraska school system in crisis.&nbsp;Gubernatorial and Nebraska Department of Education recommendations regarding the use of face coverings continue to be largely ignored by many school districts. School buildings, classrooms, and education programs are closing on a daily basis largely due to a shortage of teachers. The current situation in many school districts is not sustainable.

If schools are required to close again, there will be long-term harm to children. The closure&nbsp;will lead to severe learning loss and will be particularly damaging for students with heightened behavioral needs.&nbsp; Schools provide a stable and secure environment for developing social skills and peer relationships.&nbsp; Social interaction at school among children in grades PK-12 is particularly important for the development of language, communication, social, emotional and interpersonal skills.&nbsp; Extended school closures deprive children who live in unsafe homes and neighborhoods and offer an important layer of protection from neglect as well as physical, sexual and emotional maltreatment and abuse.&nbsp; Schools are essential to meeting the nutritional needs of children with many consuming up to half of their daily calories at school.&nbsp; When schools are closed, children lose access to important opportunities for physical activity.&nbsp; Schools play a critical role in supporting the whole child, not just their academic achievement.

Unless immediate and meaningful action is taken by the State Board to identify the mitigation strategies that must be undertaken by all schools under its jurisdiction, irreparable harm will occur to our state’s education system, educators, students and state as a whole.

The Nebraska State Board of Education is the constitutional body charged with the responsibility and authority to provide “enlightened professional leadership, guidance, and supervision of the state school system . . .”.&nbsp; NDE Rule 10 requires that schools maintain “safe, healthful, and sanitary conditions within school building(s) and on the school grounds.”&nbsp; State statute authorizes the Board to make studies, investigations, and reports for the formulation of policies, making plans, and for evaluating school programs.&nbsp;The Board must do exactly that if we are to keep our schools open and provide a safe learning environment for students and staff in this pandemic.

State statute also provides that the State Board has authority to interpret its own policies, standards, rules and regulations and, upon reasonable request, hear complaints.&nbsp;Therefore, NSEA has filed with the State Board a Petition for a Declaratory Order under NDE Rule 62 requesting that the State Board declare the following interventions and protocols be adopted as specific safety criteria under which schools will operate and remain open until the risk of COVID-19 transmission is abated.&nbsp;

1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All children in grades 3-12 must wear face coverings - with medical caveats - as well as teachers, administrators, staff and volunteers.&nbsp; If tolerated, masks should be used for children between three years of age and third grade.

2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designate a staff person to be responsible for responding to COVID-19 concerns.&nbsp; Staff, students, parents and volunteers should know who this person is and how to contact the designated staff member if they become sick or are around others diagnosed with COVID-19.&nbsp; The designated staff person should also be aware of state and local regulatory agency policies related to school guidelines and will serve as the contact with local health authorities and monitor illness among school faculty, staff and students.&nbsp; A backup person should be identified who can fill this role if the designated person becomes unavailable due to illness or other reason.

3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Establish and maintain communication and cooperation with local and state authorities to determine current levels of community mitigation.

4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Review local, state and organization guidelines for schools.&nbsp; Review your facility plans including the size of the building, all points of entry and air handling systems to understand and implement recommended state and local guidelines and the considerations detailed in this Order.

5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schools are encouraged to continue to use and develop strategies for online and other remote education technologies.

6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Develop strategies to reduce the potential for mass exposure of cases occurring in schools that include social distancing of all persons, defined and consistent groups of students and staff who remain together with limited interaction to others, considerations to reduce the maximum number of people allowed in a building based on social distancing and implementation of mask wearing requirements for indoor activities.

7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ALL sick children and adults will stay home; and, quarantine will be observed by those with COVID-19 infected persons at home.

8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All children and adults with confirmed infection will not be allowed to return to school until completing the DHM-defined period of isolation.

9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schools and public health authorities will work together to rapidly report, assess and act on frequent per school absenteeism, influenza and other disease reporting health measures.

10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Address the increased behavioral health and emotional needs of students and the mental health of teachers, staff and volunteers.

The&nbsp;<a href="https://www.nsea.org/sites/default/files/content_images/COVID19/survey/Rule%2062%20Petition%20for%20Declaratory%20Order.pdf" target="_blank">petition</a>&nbsp;further requests that the Board direct that studies, investigations and reports be prepared regarding the transmission of the virus in the school systems under its authority and take such remedial action as is necessary to enforce these safety accreditation standards.

News Release NSEAOur state public education system is facing a crisis of historic proportion due to an unprecedented surge of COVID-19.Between November 7 and November 13, on average, 124 patients with confirmed COVID-19 and 38 patients with suspected COVID-19 were reported as newly admitted each day to hospitals in Nebraska.&nbsp; On November 17, the White House Coronavirus Task Force issued a report indicating Nebraska has 101 or more new cases per 100,000 population, which is the sixth-highest infection rate in the country.&nbsp; Nebraska is also in the red zone for test positivity, indicating a rate at or above 10.1 percent, with the fourth-highest rate in the country.&nbsp; Nebraska had 735 new cases per 100,000 population, compared to a national average of 294 per 100,000.The uncontrolled transmission of the virus has put the Nebraska school system in crisis.&nbsp;Gubernatorial and Nebraska Department of Education recommendations regarding the use of face coverings continue to be largely ignored by many school districts. School buildings, classrooms, and education programs are closing on a daily basis largely due to a shortage of teachers. The current situation in many school districts is not sustainable.If schools are required to close again, there will be long-term harm to children. The closure&nbsp;will lead to severe learning loss and will be particularly damaging for students with heightened behavioral needs.&nbsp; Schools provide a stable and secure environment for developing social skills and peer relationships.&nbsp; Social interaction at school among children in grades PK-12 is particularly important for the development of language, communication, social, emotional and interpersonal skills.&nbsp; Extended school closures deprive children who live in unsafe homes and neighborhoods and offer an important layer of protection from neglect as well as physical, sexual and emotional maltreatment and abuse.&nbsp; Schools are essential to meeting the nutritional needs of children with many consuming up to half of their daily calories at school.&nbsp; When schools are closed, children lose access to important opportunities for physical activity.&nbsp; Schools play a critical role in supporting the whole child, not just their academic achievement.Unless immediate and meaningful action is taken by the State Board to identify the mitigation strategies that must be undertaken by all schools under its jurisdiction, irreparable harm will occur to our state’s education system, educators, students and state as a whole.The Nebraska State Board of Education is the constitutional body charged with the responsibility and authority to provide “enlightened professional leadership, guidance, and supervision of the state school system . . .”.&nbsp; NDE Rule 10 requires that schools maintain “safe, healthful, and sanitary conditions within school building(s) and on the school grounds.”&nbsp; State statute authorizes the Board to make studies, investigations, and reports for the formulation of policies, making plans, and for evaluating school programs.&nbsp;The Board must do exactly that if we are to keep our schools open and provide a safe learning environment for students and staff in this pandemic.State statute also provides that the State Board has authority to interpret its own policies, standards, rules and regulations and, upon reasonable request, hear complaints.&nbsp;Therefore, NSEA has filed with the State Board a Petition for a Declaratory Order under NDE Rule 62 requesting that the State Board declare the following interventions and protocols be adopted as specific safety criteria under which schools will operate and remain open until the risk of COVID-19 transmission is abated.&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All children in grades 3-12 must wear face coverings - with medical caveats - as well as teachers, administrators, staff and volunteers.&nbsp; If tolerated, masks should be used for children between three years of age and third grade.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Designate a staff person to be responsible for responding to COVID-19 concerns.&nbsp; Staff, students, parents and volunteers should know who this person is and how to contact the designated staff member if they become sick or are around others diagnosed with COVID-19.&nbsp; The designated staff person should also be aware of state and local regulatory agency policies related to school guidelines and will serve as the contact with local health authorities and monitor illness among school faculty, staff and students.&nbsp; A backup person should be identified who can fill this role if the designated person becomes unavailable due to illness or other reason.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Establish and maintain communication and cooperation with local and state authorities to determine current levels of community mitigation.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Review local, state and organization guidelines for schools.&nbsp; Review your facility plans including the size of the building, all points of entry and air handling systems to understand and implement recommended state and local guidelines and the considerations detailed in this Order.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schools are encouraged to continue to use and develop strategies for online and other remote education technologies.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Develop strategies to reduce the potential for mass exposure of cases occurring in schools that include social distancing of all persons, defined and consistent groups of students and staff who remain together with limited interaction to others, considerations to reduce the maximum number of people allowed in a building based on social distancing and implementation of mask wearing requirements for indoor activities.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ALL sick children and adults will stay home; and, quarantine will be observed by those with COVID-19 infected persons at home.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All children and adults with confirmed infection will not be allowed to return to school until completing the DHM-defined period of isolation.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Schools and public health authorities will work together to rapidly report, assess and act on frequent per school absenteeism, influenza and other disease reporting health measures.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Address the increased behavioral health and emotional needs of students and the mental health of teachers, staff and volunteers.The&nbsp;<a href="https://www.nsea.org/sites/default/files/content_images/COVID19/survey/Rule%2062%20Petition%20for%20Declaratory%20Order.pdf" target="_blank">petition</a>&nbsp;further requests that the Board direct that studies, investigations and reports be prepared regarding the transmission of the virus in the school systems under its authority and take such remedial action as is necessary to enforce these safety accreditation standards.

Nebraska teachers union petitions for strict health and safety criteria in schools

<div><iframe src="https://www.facebook.com/plugins/video.php?height=314&href=https%3A%2F%2Fwww.facebook.com%2Fwcdhd%2Fvideos%2F3405696269522143%2F&show_text=false&width=560" width="560" height="314" style="border:none;overflow:hidden" scrolling="no" frameborder="0" allowfullscreen="true" allow="autoplay; clipboard-write; encrypted-media; picture-in-picture; web-share" allowFullScreen="true"></iframe></div><figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605825806453.png" alt="Dr. James Lawler" />
 <figcaption>Dr. James Lawler</figcaption>
 </figure>

🎥 WCDHD Public Health Command Center update with Dr. James Lawler 

NORTH PLATTE, Neb. (GPH)-Great
Plains Health administered its first doses of Bamlanivimab, a
monoclonal antibody drug that recently received emergency use
authorization from the FDA in the treatment of COVID-19.

The
drug&nbsp;Bamlanivimab (BAM-la-NIH-vih-mab) is currently being allocated by
the federal government. The first shipment arrived at Great Plains
Health Wednesday and has already been used to treat multiple COVID-19
patients.

“We
have already administered the first doses of this drug to patients
and are hopeful at the results,” said Dr. Julie Query, Great Plains
Health physician. “It’s pretty incredible that a hospital of our
size and in our location is able to access drugs like this for our
patients. We are seeing a lot of cases of COVID and whenever we can
treat a patient in a way that prevents further hospitalization, we
are pleased especially right now when our hospital capacity is
already stretched.”

“We
are excited to have this drug and offer it to patients in high risk
categories that contract COVID-19,” said Jason North, Great Plains
Health pharmacy director. “Clinical trials show that it could
prevent symptoms from worsening and eliminate the need for hospital
care.” 


This
drug is not available to everyone. There are eligibility factors
considered prior to providers ordering this medication. Currently the
doses allocated to Great Plains Health are for outpatient use only
and patients must not need hospitalization or oxygen therapy.
Patients ages 12 and older that have a confirmed positive COVID-19
diagnosis and are high risk for hospitalization may be considered for
this drug among other criteria. Patients should contact their primary
care provider to find out if they are eligible. 


After
the FDA approved “emergency use” of Bamlanivimab on November 9,
the Nebraska state Department of Health and Human Services (DHHS)
invited all hospitals across the state to assess their capability to
participate in a federally funded allocation program.

In
order to receive this federally funded donation of medication, Great
Plains Health quickly mobilized a team of nursing, pharmacy and
medical staff along with the information systems department and
registration personnel to implement the logistics for safely
providing this IV infusion medication in the ER department.

“Because
of great teamwork, we successfully began administering this
medication two days ahead of the projected regional start date,”
said North. 


Bamlanivimab
is administered as a one-hour intravenous infusion, followed by
one-hour of monitoring for any possible complications. Side effects
are rare and include allergic reaction and nausea. The drug itself is
free to patients, however there are related charges associated.
Patients should contact their primary care provider who will work
with Great Plains Health to schedule an infusion if appropriate.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605826120142.png" alt="Courtesy Photo" />
 <figcaption>Courtesy Photo</figcaption>
 </figure>NORTH PLATTE, Neb. (GPH)-Great
Plains Health administered its first doses of Bamlanivimab, a
monoclonal antibody drug that recently received emergency use
authorization from the FDA in the treatment of COVID-19.The
drug&nbsp;Bamlanivimab (BAM-la-NIH-vih-mab) is currently being allocated by
the federal government. The first shipment arrived at Great Plains
Health Wednesday and has already been used to treat multiple COVID-19
patients.“We
have already administered the first doses of this drug to patients
and are hopeful at the results,” said Dr. Julie Query, Great Plains
Health physician. “It’s pretty incredible that a hospital of our
size and in our location is able to access drugs like this for our
patients. We are seeing a lot of cases of COVID and whenever we can
treat a patient in a way that prevents further hospitalization, we
are pleased especially right now when our hospital capacity is
already stretched.”“We
are excited to have this drug and offer it to patients in high risk
categories that contract COVID-19,” said Jason North, Great Plains
Health pharmacy director. “Clinical trials show that it could
prevent symptoms from worsening and eliminate the need for hospital
care.” 
This
drug is not available to everyone. There are eligibility factors
considered prior to providers ordering this medication. Currently the
doses allocated to Great Plains Health are for outpatient use only
and patients must not need hospitalization or oxygen therapy.
Patients ages 12 and older that have a confirmed positive COVID-19
diagnosis and are high risk for hospitalization may be considered for
this drug among other criteria. Patients should contact their primary
care provider to find out if they are eligible. 
After
the FDA approved “emergency use” of Bamlanivimab on November 9,
the Nebraska state Department of Health and Human Services (DHHS)
invited all hospitals across the state to assess their capability to
participate in a federally funded allocation program.In
order to receive this federally funded donation of medication, Great
Plains Health quickly mobilized a team of nursing, pharmacy and
medical staff along with the information systems department and
registration personnel to implement the logistics for safely
providing this IV infusion medication in the ER department.“Because
of great teamwork, we successfully began administering this
medication two days ahead of the projected regional start date,”
said North. 
Bamlanivimab
is administered as a one-hour intravenous infusion, followed by
one-hour of monitoring for any possible complications. Side effects
are rare and include allergic reaction and nausea. The drug itself is
free to patients, however there are related charges associated.
Patients should contact their primary care provider who will work
with Great Plains Health to schedule an infusion if appropriate.

Great Plains Health among first in Nebraska to administer drug to prevent COVID-19 hospitalizations

OMAHA, Neb. (AP) - A prominent Nebraska infectious disease expert sounded the alarm Thursday about the state's surging coronavirus cases and called for a statewide mask mandate, a step Gov. Pete Ricketts has repeatedly refused to take.

Dr. James Lawler, an infectious disease specialist at the University of Nebraska Medical Center, said the pandemic has reached its most dangerous point since it began and described the recent increase in virus hospitalizations as unsustainable.

"I've been in mass-casualty situations in combat zones in Afghanistan, I've been in Ebola treatment centers in very austere conditions, and I have never been as frightened about the status of the health system as I am about the status of our health care system in Nebraska right now," Lawler said during a video conference call.

Nebraska hospitals are straining to cope with the spike in coronavirus patients, and officials are urging the public to wear masks and take other precautionary steps to slow the spread of the disease. The virus has been surging in Nebraska, with more than five times as many COVID-19 hospitalizations as of Wednesday than the 185 it had two months ago.

Nebraska limits indoor gatherings to 25% of a space's capacity and requires people to wear masks at businesses where employees and customers are in close contact for more than 15 minutes, such as salons. At bars and restaurants, groups are limited to eight people and tables must be six feet apart.

But Ricketts has resisted imposing a statewide order broadly requiring people to wear masks in public, relying instead on individuals to take responsibility for wearing them. Ricketts said Thursday that the state does require masks for some people, such as restaurant workers, but he remains opposed to "broad-based mandates."

"We do have mask requirements where appropriate," he said.

Ricketts and Lawler both spoke on a video-chat news conference to announce a new public relations campaign dubbed "Do Right, Right Now."

Ricketts has said he would impose more restrictions if 25% of hospitalizations in the state are for COVID-19, but that rate stood at 21% on Wednesday.

"Hospitalizations are spiking and we have to bend that curve," said Dr. Gary Anthone, the state's chief medical officer. "Hospital staff provide critical care for us when we need it most, and right now they are flooded with patients and telling us they need our help."

The number of people hospitalized with the coronavirus decreased slightly on Wednesday to 961, from 978 on Tuesday. The state reported its second-highest daily total of new confirmed cases on Wednesday, 2,812, which raised its overall total since the pandemic began to 106,617. It reported 10 new deaths, raising its COVID-19 death toll to 826, according to the state's&nbsp;<a href="https://experience.arcgis.com/experience/ece0db09da4d4ca68252c3967aa1e9dd" target="_blank">online virus tracker</a>.

Nebraska has the sixth-highest rate of infection in the country. Over the past week, one out of every 116 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.

The seven-day rolling average of daily new cases in Nebraska has risen over the past two weeks from roughly 1,241 new cases per day on Nov. 4 to 2,296 new cases per day as of Wednesday.

Lawler implored residents to heed the warnings of scientists and doctors who are trying to stop the pandemic.

"The reason that we ask for (mask) mandates it that we know they work," he said. "Compliance increases (and) mandates result in a reduction in cases and in fatalities."

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605825806453.png" alt="Dr. James Lawler (UNMC Photo)" />
 <figcaption>Dr. James Lawler (UNMC Photo)</figcaption>
 </figure>By GRANT SCHULTE-Associated Press OMAHA, Neb. (AP) - A prominent Nebraska infectious disease expert sounded the alarm Thursday about the state's surging coronavirus cases and called for a statewide mask mandate, a step Gov. Pete Ricketts has repeatedly refused to take.Dr. James Lawler, an infectious disease specialist at the University of Nebraska Medical Center, said the pandemic has reached its most dangerous point since it began and described the recent increase in virus hospitalizations as unsustainable."I've been in mass-casualty situations in combat zones in Afghanistan, I've been in Ebola treatment centers in very austere conditions, and I have never been as frightened about the status of the health system as I am about the status of our health care system in Nebraska right now," Lawler said during a video conference call.Nebraska hospitals are straining to cope with the spike in coronavirus patients, and officials are urging the public to wear masks and take other precautionary steps to slow the spread of the disease. The virus has been surging in Nebraska, with more than five times as many COVID-19 hospitalizations as of Wednesday than the 185 it had two months ago.Nebraska limits indoor gatherings to 25% of a space's capacity and requires people to wear masks at businesses where employees and customers are in close contact for more than 15 minutes, such as salons. At bars and restaurants, groups are limited to eight people and tables must be six feet apart.But Ricketts has resisted imposing a statewide order broadly requiring people to wear masks in public, relying instead on individuals to take responsibility for wearing them. Ricketts said Thursday that the state does require masks for some people, such as restaurant workers, but he remains opposed to "broad-based mandates.""We do have mask requirements where appropriate," he said.Ricketts and Lawler both spoke on a video-chat news conference to announce a new public relations campaign dubbed "Do Right, Right Now."Ricketts has said he would impose more restrictions if 25% of hospitalizations in the state are for COVID-19, but that rate stood at 21% on Wednesday."Hospitalizations are spiking and we have to bend that curve," said Dr. Gary Anthone, the state's chief medical officer. "Hospital staff provide critical care for us when we need it most, and right now they are flooded with patients and telling us they need our help."The number of people hospitalized with the coronavirus decreased slightly on Wednesday to 961, from 978 on Tuesday. The state reported its second-highest daily total of new confirmed cases on Wednesday, 2,812, which raised its overall total since the pandemic began to 106,617. It reported 10 new deaths, raising its COVID-19 death toll to 826, according to the state's&nbsp;<a href="https://experience.arcgis.com/experience/ece0db09da4d4ca68252c3967aa1e9dd" target="_blank">online virus tracker</a>.Nebraska has the sixth-highest rate of infection in the country. Over the past week, one out of every 116 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.The seven-day rolling average of daily new cases in Nebraska has risen over the past two weeks from roughly 1,241 new cases per day on Nov. 4 to 2,296 new cases per day as of Wednesday.Lawler implored residents to heed the warnings of scientists and doctors who are trying to stop the pandemic."The reason that we ask for (mask) mandates it that we know they work," he said. "Compliance increases (and) mandates result in a reduction in cases and in fatalities."

Top Nebraska pandemic expert 'frightened' about rising cases

OMAHA, Neb. (AP) - Nebraska hospitals are straining to cope with the spike in coronavirus patients, and officials are urging the public to wear masks and take other precautionary steps to slow the spread of the disease even if the governor thus far has refused to issue a broad order requiring them to do so.

The virus has been surging in Nebraska, with more than five times as many COVID-19 hospitalizations as of Wednesday than the 185 it had two months ago.

But Gov. Pete Ricketts has resisted imposing a statewide order broadly requiring people to wear masks in public, relying instead on individuals to take responsibility for wearing them. He has said he would impose more restrictions if 25% of hospitalizations in the state are for COVID-19, but that rate stood at 21% on Wednesday.

OMAHA, Neb. (AP) - Nebraska hospitals are straining to cope with the spike in coronavirus patients, and officials are urging the public to wear masks and take other precautionary steps to slow the spread of the disease even if the governor thus far has refused to issue a broad order requiring them to do so.The virus has been surging in Nebraska, with more than five times as many COVID-19 hospitalizations as of Wednesday than the 185 it had two months ago.Nebraska limits indoor gatherings to 25% of a space's capacity and requires people to wear masks at businesses where employees and customers are in close contact for more than 15 minutes, such as salons. At bars and restaurants, groups are limited to eight people and tables must be six feet apart.But Gov. Pete Ricketts has resisted imposing a statewide order broadly requiring people to wear masks in public, relying instead on individuals to take responsibility for wearing them. He has said he would impose more restrictions if 25% of hospitalizations in the state are for COVID-19, but that rate stood at 21% on Wednesday."Hospitalizations are spiking and we have to bend that curve," said Dr. Gary Anthone, the state's chief medical officer. "Hospital staff provide critical care for us when we need it most, and right now they are flooded with patients and telling us they need our help."The number of people hospitalized with the coronavirus decreased slightly on Wednesday to 961, from 978 on Tuesday. The state reported its second-highest daily total of new confirmed cases on Wednesday, 2,812, which raised its overall total since the pandemic began to 106,617. It reported 10 new deaths, raising its COVID-19 death toll to 826, according to the state's&nbsp;<a href="https://experience.arcgis.com/experience/ece0db09da4d4ca68252c3967aa1e9dd" target="_blank">online virus tracker</a>.Nebraska has the sixth-highest rate of infection in the country. Over the past week, one out of every 116 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.The seven-day rolling average of daily new cases in Nebraska has risen over the past two weeks from roughly 1,241 new cases per day on Nov. 4 to 2,296 new cases per day as of Wednesday.

Nebraska hospitals straining to cope with coronavirus surge

OMAHA, Neb. (AP) - Nebraska virus cases jumped again Wednesday with nearly 3,000 new cases.

The state reported its second-highest one day total at 2,812 Wednesday to give the state 106,617 cases. Nebraska also reported 10 new deaths for a total of 826.

The number of people hospitalized with the coronavirus decreased slightly to 961 Wednesday from the previous day's 978, but the total number of hospitalizations remains more than five times higher than it was two months ago when 185 people were being treated.

The state said 21% of Nebraska's hospital beds were filled with COVID-19 patients on Wednesday. Gov. Pete Ricketts has said he will impose more social distancing restrictions if that number reaches 25% of all hospitalizations.

Nebraska continues to have the sixth-highest rate of infection in the country. Over the past week, one person in every 116 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.

The seven-day rolling average of daily new cases in Nebraska has risen over the past two weeks from 1,240.57 new cases per day on Nov. 4 to 2,296 new cases per day on Wednesday.

OMAHA, Neb. (AP) - Nebraska virus cases jumped again Wednesday with nearly 3,000 new cases.The state reported its second-highest one day total at 2,812 Wednesday to give the state 106,617 cases. Nebraska also reported 10 new deaths for a total of 826.The number of people hospitalized with the coronavirus decreased slightly to 961 Wednesday from the previous day's 978, but the total number of hospitalizations remains more than five times higher than it was two months ago when 185 people were being treated.The state said 21% of Nebraska's hospital beds were filled with COVID-19 patients on Wednesday. Gov. Pete Ricketts has said he will impose more social distancing restrictions if that number reaches 25% of all hospitalizations.Nebraska continues to have the sixth-highest rate of infection in the country. Over the past week, one person in every 116 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.The seven-day rolling average of daily new cases in Nebraska has risen over the past two weeks from 1,240.57 new cases per day on Nov. 4 to 2,296 new cases per day on Wednesday.

Nebraska virus cases jump nearly 3,000 Wednesday

OMAHA, Neb. (AP) - More Nebraska cities are passing mask mandates as the number of virus cases continues to surge across the state, but Gov. Pete Ricketts continues to reject the idea of a statewide mask mandate.

Kearney and Beatrice passed mask requirements Tuesday to join Lincoln and Omaha as Nebraska cities that require people to wear masks. Several other cities, including Grand Island and Hastings, are also considering approving mask rules, according to the&nbsp;<a href="https://omaha.com/news/state-and-regional/beatrice-kearney-enact-mask-mandates-gov-ricketts-says-he-wont-interfere/article_5f5b7b36-a030-5048-b2cc-2ebf4cf801f2.html" target="_blank">Omaha World-Herald</a>.

"In my heart of hearts this is something we need to do to defeat this. COVID is something you don't want to mess with," Kearney Mayor Stan Clouse said before the City Council voted unanimously to enact the mask ordinance. Kearney's rule will go into effect Monday and last at least through Feb. 23.

Statewide, masks are required at businesses where employees and customers are in close contact for more that 15 minutes, such as at salons and barbershops, but Ricketts continues to resist requiring them in all circumstances. The Republican has said he believes educating people about the benefits of wearing masks is more effective than a mandate, which he believes will&nbsp;<a href="https://apnews.com/article/pete-ricketts-nebraska-coronavirus-pandemic-omaha-373e843793a8c92529b2d868d8ee75f0" target="_blank">generate resistance</a>.

In Beatrice, the local Board of Health passed a rule requiring masks in all indoor public spaces because virus cases have been rising steadily in the area. But Beatrice Police Chief Bruce Lang said he doesn't expect to be ticketing people for not wearing masks.

"I can't stress this enough that our hope is that we have voluntary compliance," he said.

Nebraska officials said 2,204 new virus cases were reported Tuesday to give the state 103,805 cases. There were also 19 new deaths reported to push the state's total up to 816, according to the state's&nbsp;<a href="https://experience.arcgis.com/experience/ece0db09da4d4ca68252c3967aa1e9dd" target="_blank">online virus tracker.</a>

The number of people hospitalized with the virus set another new record Tuesday when it increased to 978 from the previous day's 938. The number of hospitalizations is straining hospital capacity across the state, and it has more than quadrupled since the start of October.

Ricketts has said he will impose additional social distancing restrictions if the number of hospitalizations approaches 1,200 because that would mean that COVID-19 patients account for 25% of all hospital patients statewide.

Nebraska continues to have the sixth-highest rate of new cases in the country. Over the past week, one out of every 120 people in the state has been diagnosed with COVID-19.

The seven-day rolling average of daily new cases in Nebraska has nearly doubled over the past two weeks from 1,160.14 new cases per day on Nov. 3 to 2,292.86 new cases per day on Tuesday.

The number of deaths the state is reporting is also on the rise. On Tuesday, the seven-day rolling average of deaths reported each day was 12.43, up from 7.57 per day on Nov. 3.

OMAHA, Neb. (AP) - More Nebraska cities are passing mask mandates as the number of virus cases continues to surge across the state, but Gov. Pete Ricketts continues to reject the idea of a statewide mask mandate.Kearney and Beatrice passed mask requirements Tuesday to join Lincoln and Omaha as Nebraska cities that require people to wear masks. Several other cities, including Grand Island and Hastings, are also considering approving mask rules, according to the&nbsp;<a href="https://omaha.com/news/state-and-regional/beatrice-kearney-enact-mask-mandates-gov-ricketts-says-he-wont-interfere/article_5f5b7b36-a030-5048-b2cc-2ebf4cf801f2.html" target="_blank">Omaha World-Herald</a>."In my heart of hearts this is something we need to do to defeat this. COVID is something you don't want to mess with," Kearney Mayor Stan Clouse said before the City Council voted unanimously to enact the mask ordinance. Kearney's rule will go into effect Monday and last at least through Feb. 23.Statewide, masks are required at businesses where employees and customers are in close contact for more that 15 minutes, such as at salons and barbershops, but Ricketts continues to resist requiring them in all circumstances. The Republican has said he believes educating people about the benefits of wearing masks is more effective than a mandate, which he believes will&nbsp;<a href="https://apnews.com/article/pete-ricketts-nebraska-coronavirus-pandemic-omaha-373e843793a8c92529b2d868d8ee75f0" target="_blank">generate resistance</a>.In Beatrice, the local Board of Health passed a rule requiring masks in all indoor public spaces because virus cases have been rising steadily in the area. But Beatrice Police Chief Bruce Lang said he doesn't expect to be ticketing people for not wearing masks."I can't stress this enough that our hope is that we have voluntary compliance," he said.Nebraska officials said 2,204 new virus cases were reported Tuesday to give the state 103,805 cases. There were also 19 new deaths reported to push the state's total up to 816, according to the state's&nbsp;<a href="https://experience.arcgis.com/experience/ece0db09da4d4ca68252c3967aa1e9dd" target="_blank">online virus tracker.</a>The number of people hospitalized with the virus set another new record Tuesday when it increased to 978 from the previous day's 938. The number of hospitalizations is straining hospital capacity across the state, and it has more than quadrupled since the start of October.Ricketts has said he will impose additional social distancing restrictions if the number of hospitalizations approaches 1,200 because that would mean that COVID-19 patients account for 25% of all hospital patients statewide.Nebraska continues to have the sixth-highest rate of new cases in the country. Over the past week, one out of every 120 people in the state has been diagnosed with COVID-19.The seven-day rolling average of daily new cases in Nebraska has nearly doubled over the past two weeks from 1,160.14 new cases per day on Nov. 3 to 2,292.86 new cases per day on Tuesday.The number of deaths the state is reporting is also on the rise. On Tuesday, the seven-day rolling average of deaths reported each day was 12.43, up from 7.57 per day on Nov. 3.

More Nebraska cities approve mask mandates to limit virus

WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be <a href="https://www.lucirahealth.com/">performed entirely at home</a> and delivers results in 30 minutes.

The announcement by the Food and Drug Administration represents an important step in U.S. efforts to expand testing options for COVID-19 beyond health care facilities and testing sites. However, the test will require a prescription, likely limiting its initial use.

The FDA granted emergency authorization to the single-use <a href="https://www.lucirahealth.com/">test kit from Lucira Health</a>, a California manufacturer.

The company’s test allows users to swab themselves to collect a nasal sample. The sample is then swirled in a vial of laboratory solution that plugs into a portable device. Results are displayed as lights labeled positive or negative.

To date, the FDA has authorized nearly 300 tests for coronavirus. The vast majority require a nasal swab performed by a health professional and must be processed at laboratories using high-tech equipment. A handful of tests allow people to collect their own sample at home — a nasal swab or saliva — that’s then shipped to a lab, which usually means waiting days for results.

Health experts have called for options to allow people to test themselves at home, reducing turnaround times and the potential spread of the virus to others, including health care workers. Rapid test results are critical to quickly quarantining those who are infected and tracing their contacts. But for months, U.S. testing has been plagued by slow results due to bottlenecks as testing laboratories. There are other rapid tests but most require a small, special machine operated by a health professional to develop results

“Now, more Americans who may have COVID-19 will be able to take immediate action, based on their results, to protect themselves and those around them,” Dr. Jeff Shuren, director of the FDA’s devices center, said in a statement.

Lucira did not immediately respond to a request for additional details after business hours Tuesday.

The Lucira COVID-19 test grew out of research the company was doing to develop an at-home flu test, according to the company’s website. Lucira adapted its technology to detect COVID-19 after the outbreak.

The test uses technology similar to genetic laboratory-based tests that are the standard tool for COVID-19 screening. That’s different than most rapid tests currently used in the U.S., which look for viral proteins called antigens — not the virus itself.

Anyone that tests positive should isolate and seek care from a health professional, the FDA said in its release. Those who test negative but still have coronavirus symptoms should consult a doctor; a negative result does not rule out COVID-19 infection.

The FDA said Lucira’s test was also authorized for use in doctor’s offices and testing sites. Currently all U.S. testing sites must report results to state and federal health authorities tracking the pandemic. Doctors will be required to report the home test results.

“If the results are not reported back, it may be difficult to figure out what is happening in the community at large,” said Dr. Alberto Gutierrez, former head of the FDA’s testing office, in an interview before the announcement.

More than two dozen companies have been racing for months to develop the first, rapid home-based test for COVID-19. However, the FDA outlined a number of study requirements for manufacturers.

These hurdles have less to do with COVID-19 specifically, and more to do with decades-long concerns about whether people without any medical training can accurately screen themselves and interpret the results.

The FDA has only ever approved one home test for an infectious disease — an HIV test. And even commonplace over-the-counter tests— such as home pregnancy kits — were subject to years of scrutiny before FDA allowed their use in the 1970s.

Experts say that careful approach is warranted for coronavirus.

“I think increased testing closer to patients, including in the home, is the way of the future,” said Dr. Robin Patel of the Mayo Clinic, in an interview before the announcement was made. “But there are considerations that have to be addressed to make sure that this is done in a safe and effective way.”

FDA regulators authorized the new test using their emergency powers to quickly speed the availability of experimental products during public health crises. In normal times, the FDA requires evidence of safety and effectiveness before clearing a new test. But during public health emergencies the agency can lower those standards.

The FDA release did not disclose the test’s accuracy or the study results that regulators used to make the decision.

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605699600232.png" alt="photo courtesy Lucira Health" />
 <figcaption>photo courtesy Lucira Health</figcaption>
 </figure>WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be <a href="https://www.lucirahealth.com/">performed entirely at home</a> and delivers results in 30 minutes.The announcement by the Food and Drug Administration represents an important step in U.S. efforts to expand testing options for COVID-19 beyond health care facilities and testing sites. However, the test will require a prescription, likely limiting its initial use.The FDA granted emergency authorization to the single-use <a href="https://www.lucirahealth.com/">test kit from Lucira Health</a>, a California manufacturer.The company’s test allows users to swab themselves to collect a nasal sample. The sample is then swirled in a vial of laboratory solution that plugs into a portable device. Results are displayed as lights labeled positive or negative.To date, the FDA has authorized nearly 300 tests for coronavirus. The vast majority require a nasal swab performed by a health professional and must be processed at laboratories using high-tech equipment. A handful of tests allow people to collect their own sample at home — a nasal swab or saliva — that’s then shipped to a lab, which usually means waiting days for results.Health experts have called for options to allow people to test themselves at home, reducing turnaround times and the potential spread of the virus to others, including health care workers. Rapid test results are critical to quickly quarantining those who are infected and tracing their contacts. But for months, U.S. testing has been plagued by slow results due to bottlenecks as testing laboratories. There are other rapid tests but most require a small, special machine operated by a health professional to develop results“Now, more Americans who may have COVID-19 will be able to take immediate action, based on their results, to protect themselves and those around them,” Dr. Jeff Shuren, director of the FDA’s devices center, said in a statement.Lucira did not immediately respond to a request for additional details after business hours Tuesday.The Lucira COVID-19 test grew out of research the company was doing to develop an at-home flu test, according to the company’s website. Lucira adapted its technology to detect COVID-19 after the outbreak.The test uses technology similar to genetic laboratory-based tests that are the standard tool for COVID-19 screening. That’s different than most rapid tests currently used in the U.S., which look for viral proteins called antigens — not the virus itself.Anyone that tests positive should isolate and seek care from a health professional, the FDA said in its release. Those who test negative but still have coronavirus symptoms should consult a doctor; a negative result does not rule out COVID-19 infection.The FDA said Lucira’s test was also authorized for use in doctor’s offices and testing sites. Currently all U.S. testing sites must report results to state and federal health authorities tracking the pandemic. Doctors will be required to report the home test results.“If the results are not reported back, it may be difficult to figure out what is happening in the community at large,” said Dr. Alberto Gutierrez, former head of the FDA’s testing office, in an interview before the announcement.More than two dozen companies have been racing for months to develop the first, rapid home-based test for COVID-19. However, the FDA outlined a number of study requirements for manufacturers.These hurdles have less to do with COVID-19 specifically, and more to do with decades-long concerns about whether people without any medical training can accurately screen themselves and interpret the results.The FDA has only ever approved one home test for an infectious disease — an HIV test. And even commonplace over-the-counter tests— such as home pregnancy kits — were subject to years of scrutiny before FDA allowed their use in the 1970s.Experts say that careful approach is warranted for coronavirus.“I think increased testing closer to patients, including in the home, is the way of the future,” said Dr. Robin Patel of the Mayo Clinic, in an interview before the announcement was made. “But there are considerations that have to be addressed to make sure that this is done in a safe and effective way.”FDA regulators authorized the new test using their emergency powers to quickly speed the availability of experimental products during public health crises. In normal times, the FDA requires evidence of safety and effectiveness before clearing a new test. But during public health emergencies the agency can lower those standards.The FDA release did not disclose the test’s accuracy or the study results that regulators used to make the decision.___

FDA allows 1st rapid virus test that gives results at home

As testing for COVID-19 ramp up, so do the number of confirmed cases in the West Central District Health Department jurisdiction.

WCDHD reported 64 new positive cases in their jurisdiction on Tuesday.

Officials say one case is from Thomas County, two cases are from Logan County, two cases are from McPherson County, and 59 cases are from Lincoln County.

There are currently 1, 367 active cases of COVID-19 in the WCDHD jurisdiction with 60 people currently hospitalized with the virus.&nbsp;

According to data, there are four Intensive Care Unit beds available at Great Plains Health.&nbsp;

For more data and information, visit the <a href="https://public.tableau.com/profile/sydney.keller5172#!/vizhome/WestCentralDistrictHealthDepartmentCOVID-19Dashboard/CaseInformation">WCDHD COVID-19 Dashboard</a>.

As testing for COVID-19 ramp up, so do the number of confirmed cases in the West Central District Health Department jurisdiction.WCDHD reported 64 new positive cases in their jurisdiction on Tuesday.Officials say one case is from Thomas County, two cases are from Logan County, two cases are from McPherson County, and 59 cases are from Lincoln County.There are currently 1, 367 active cases of COVID-19 in the WCDHD jurisdiction with 60 people currently hospitalized with the virus.&nbsp;According to data, there are four Intensive Care Unit beds available at Great Plains Health.&nbsp;For more data and information, visit the <a href="https://public.tableau.com/profile/sydney.keller5172#!/vizhome/WestCentralDistrictHealthDepartmentCOVID-19Dashboard/CaseInformation">WCDHD COVID-19 Dashboard</a>.<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605705873300.png" alt="As of November 18, 2020" />
 <figcaption>As of November 18, 2020</figcaption>
 </figure><figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605705692741.png" alt="" />
 <figcaption></figcaption>
 </figure>

64 new confirmed COVID cases in WCDHD jurisdiction on Tuesday, few ICU beds available

Pfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that the vaccine protects older people most at risk of dying from COVID-19.

The announcement, just a week after Pfizer first revealed promising preliminary&nbsp;<a href="https://apnews.com/article/pfizer-vaccine-effective-early-data-4f4ae2e3bad122d17742be22a2240ae8">results</a>, comes as the company is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.

Pfizer initially had estimated its vaccine, developed with German partner BioNTech, was more than 90% effective after 94 infections had been counted. With Wednesday’s announcement, the company now has accumulated 170 infections in the study -- and said only eight of them occurred in volunteers who got the actual vaccine rather than a dummy shot. One of those eight developed severe disease, the company said.

The company has not yet released detailed data on its study, and results have not been analyzed by independent experts.

Pfizer said its vaccine was more than 94% effective in adults over age 65, though it is not clear how the company determined effectiveness in older adults, with only eight infections in the vaccinated group to analyze and no breakdown provided of those people’s ages.

Earlier this week Moderna, Inc. announced that its experimental vaccine appears to be 94.5%&nbsp;<a href="https://apnews.com/article/2nd-virus-vaccine-success-us-tests-5575a8a8ca3825a9bf39a5d234aba07b">effective</a>&nbsp;after an interim analysis of its late-stage study.

Pfizer says it now has the data on the vaccine’s safety needed to seek emergency authorization from the Food and Drug Administration.

The company didn’t disclose safety details but said no serious vaccine side effects have been reported, with the most common problem being fatigue after the second vaccine dose, affecting about 4% of participants.

The study has enrolled nearly 44,000 people in the U.S. and five other countries. The trial will continue to collect safety and efficacy data on volunteers for two more years.

Pfizer and BioNTech said they expect to produce up to 50 million vaccine doses globally in 2020 and up to 1.3 billion doses in 2021.

U.S. officials have said they hope to have about 20 million vaccine doses each from Moderna and Pfizer available for distribution in late December. The first shots will be offered to vulnerable groups like medical and nursing home workers, and people with serious health conditions.

By LINDA A. JOHNSON-Associated PressPfizer says that more interim results from its ongoing coronavirus vaccine study suggest the shots are 95% effective and that the vaccine protects older people most at risk of dying from COVID-19.The announcement, just a week after Pfizer first revealed promising preliminary&nbsp;<a href="https://apnews.com/article/pfizer-vaccine-effective-early-data-4f4ae2e3bad122d17742be22a2240ae8">results</a>, comes as the company is preparing within days to formally ask U.S. regulators to allow emergency use of the vaccine.Pfizer initially had estimated its vaccine, developed with German partner BioNTech, was more than 90% effective after 94 infections had been counted. With Wednesday’s announcement, the company now has accumulated 170 infections in the study -- and said only eight of them occurred in volunteers who got the actual vaccine rather than a dummy shot. One of those eight developed severe disease, the company said.The company has not yet released detailed data on its study, and results have not been analyzed by independent experts.Pfizer said its vaccine was more than 94% effective in adults over age 65, though it is not clear how the company determined effectiveness in older adults, with only eight infections in the vaccinated group to analyze and no breakdown provided of those people’s ages.Earlier this week Moderna, Inc. announced that its experimental vaccine appears to be 94.5%&nbsp;<a href="https://apnews.com/article/2nd-virus-vaccine-success-us-tests-5575a8a8ca3825a9bf39a5d234aba07b">effective</a>&nbsp;after an interim analysis of its late-stage study.Pfizer says it now has the data on the vaccine’s safety needed to seek emergency authorization from the Food and Drug Administration.The company didn’t disclose safety details but said no serious vaccine side effects have been reported, with the most common problem being fatigue after the second vaccine dose, affecting about 4% of participants.The study has enrolled nearly 44,000 people in the U.S. and five other countries. The trial will continue to collect safety and efficacy data on volunteers for two more years.Pfizer and BioNTech said they expect to produce up to 50 million vaccine doses globally in 2020 and up to 1.3 billion doses in 2021.U.S. officials have said they hope to have about 20 million vaccine doses each from Moderna and Pfizer available for distribution in late December. The first shots will be offered to vulnerable groups like medical and nursing home workers, and people with serious health conditions.

Pfizer: COVID-19 shot 95% effective, seeking clearance soon

LINCOLN, Neb.-Governor Pete Ricketts held a press conference to provide an update on the State’s coronavirus response.&nbsp; He reminded Nebraskans that the State will move to more restrictive health measures when coronavirus hospitalizations reach 25% of the state’s staffed hospital beds. &nbsp;The Governor also renewed his call for Nebraskans to keep six feet from others in public, to wear a mask when this distance isn’t possible, and to stay home when sick.

Craig Buescher, a team member with the University of Nebraska Foundation, joined the Governor at this afternoon’s briefing.&nbsp; He shared his story of coming down with the coronavirus, being hospitalized, and dealing with symptoms as he recovers.

The State’s Chief Medical Officer Dr. Gary Anthone walked through the various treatments being used to help coronavirus patients get better.&nbsp; He also advised Nebraskans to consider taking vitamin D supplements.&nbsp; Having normal vitamin D levels has been shown to help patients as they battle coronavirus.

Craig Buescher: Coronavirus Survivor Testimonial&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Dr. Gary Anthone: Coronavirus Treatments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Video from today’s press conference is available by&nbsp;<a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.dropbox.com%2Fs%2Fdl2vw6o99z6i20n%2FGov.%2520Press%2520Conf%252011.17.2020.mp4%3Fdl%3D0&amp;data=04%7C01%7Ccio.webmstr%40nebraska.gov%7C8658fc8a42a84e42a04208d88b51247c%7C043207dfe6894bf6902001038f11f0b1%7C0%7C0%7C637412527905796001%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=2IC%2FCB1OuI3QuWey3j%2Fw4uypHOncDOwLOhXD3NvL4IA%3D&amp;reserved=0" target="_blank">clicking here</a>.

To see a chart of the restrictions in each colored phase of the State’s coronavirus response,&nbsp;<a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.dropbox.com%2Fs%2Fhmadcuih3j2xlyd%2FColor-Coded%2520%2520Phase%2520Comparison%252011.13.20.pdf%3Fdl%3D0&amp;data=04%7C01%7Ccio.webmstr%40nebraska.gov%7C8658fc8a42a84e42a04208d88b51247c%7C043207dfe6894bf6902001038f11f0b1%7C0%7C0%7C637412527905796001%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=XpI7uYy8muT6M1r62SNWznUP6ctJE50qXLn9wYHRadg%3D&amp;reserved=0" target="_blank">click here</a>.&nbsp;

<figure>
 <img src="https://media.eaglewebservices.com/public/2020/11/1605664494613.png" alt="Gov. Ricketts (TV screen) and Craig Buescher (podium), University of Nebraska Foundation team member, at this afternoon’s press briefing." />
 <figcaption>Gov. Ricketts (TV screen) and Craig Buescher (podium), University of Nebraska Foundation team member, at this afternoon’s press briefing.</figcaption>
 </figure>LINCOLN, Neb.-Governor Pete Ricketts held a press conference to provide an update on the State’s coronavirus response.&nbsp; He reminded Nebraskans that the State will move to more restrictive health measures when coronavirus hospitalizations reach 25% of the state’s staffed hospital beds. &nbsp;The Governor also renewed his call for Nebraskans to keep six feet from others in public, to wear a mask when this distance isn’t possible, and to stay home when sick.Craig Buescher, a team member with the University of Nebraska Foundation, joined the Governor at this afternoon’s briefing.&nbsp; He shared his story of coming down with the coronavirus, being hospitalized, and dealing with symptoms as he recovers.The State’s Chief Medical Officer Dr. Gary Anthone walked through the various treatments being used to help coronavirus patients get better.&nbsp; He also advised Nebraskans to consider taking vitamin D supplements.&nbsp; Having normal vitamin D levels has been shown to help patients as they battle coronavirus.Gov. Ricketts: Protecting Hospitals<ul>
 <li>We’ve seen a tremendous increase in hospitalizations over the past several weeks.&nbsp; On September 23rd, we had 200 coronavirus-related hospitalizations in Nebraska. &nbsp;Today, those hospitalizations are at 938.</li><li>It’s urgently important for all of us to take personal responsibility to support our healthcare workers, protect hospital capacity, and slow the spread of the virus.&nbsp;</li><li>We can do this by wearing a mask, washing our hands often, staying home when sick, and keeping six feet of social distance.&nbsp;</li><li>Last Friday, I announced that Nebraska will move into the “red” phase of our health restrictions when coronavirus hospitalizations reach 25% of the staffed hospital beds in Nebraska.&nbsp; We’re calculating the number of staffed hospital beds on a 14-day rolling average.Currently, we’re in the “orange” phase, and coronavirus patients occupy just over 20% of staffed hospital beds in Nebraska.</li><li>We’re calculating the number of staffed hospital beds on a 14-day rolling average.</li><li>Currently, we’re in the “orange” phase, and coronavirus patients occupy just over 20% of staffed hospital beds in Nebraska.</li>
 </ul>Craig Buescher: Coronavirus Survivor Testimonial&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<ul>
 <li>Two months ago, I was diagnosed with coronavirus.</li><li>I had symptoms prior to the diagnosis.&nbsp; My legs felt weak, and I was tired all of the time.</li><li>When I first went to the doctor, he advised me to monitor my symptoms for a couple of days.</li><li>I then developed new symptoms of high temperature and limited breathing. &nbsp;I returned to the doctor, who tested me and confirmed that I had coronavirus.</li><li>My doctor asked me to monitor my blood oxygen levels and to go to the ER if my levels fell below 90.</li><li>When my levels fell below 90, my wife took me to the ER.</li><li>I spent nine days in the hospital. &nbsp;My main problem was difficulty breathing.&nbsp; My legs were also weak, and I had to hang on to something to keep from falling.</li><li>To be honest, I didn’t take the coronavirus very seriously prior to getting ill. I wore a mask most of the time, but I thought I’d be able to fight off the virus pretty easily if I got it.After having the coronavirus, I’m a believer in its danger.</li><li>I wore a mask most of the time, but I thought I’d be able to fight off the virus pretty easily if I got it.</li><li>After having the coronavirus, I’m a believer in its danger.</li><li>I encourage Nebraskans to plan ahead for the holidays.</li><li>We’ve chosen not to gather as a family for Thanksgiving to prevent anyone transmitting the virus.&nbsp; It’ll be tough not getting together with our kids, but we can make the best of it through social media.</li>
 </ul>Dr. Gary Anthone: Coronavirus Treatments&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<ul>
 <li>There are common treatments being used for coronavirus patients. RemdesivirThis antiviral medication slows down the replication of the virus.Early studies showed that remdesivir reduced COVID-19 recovery times from 15 to 10 days.While initially only used in the late stages of COVID-19 illness, it’s now used as soon as a patient is found to need oxygen therapy.DexamethasoneThis steroid medication is used to modulate your body’s inflammatory response against COVID-19.It has demonstrated a 35% decrease in mortality in patients on ventilators and a 20% decrease in patients requiring oxygen.It has not been shown to benefit patients who did not require oxygen.Convalescent PlasmaThe FDA approved its use in August for patients with severe and life-threatening infections.It’s plasma from donors with prior COVID-19 infection which has antibodies to fight the coronavirus.&nbsp;Monoclonal AntibodiesThis lab-created antibody directly neutralizes the coronavirus to prevent progression of the disease.It’s typically given in outpatient settings to prevent a patient from becoming ill to the point of needing hospitalization.&nbsp; It’s given right after a patient tests positive, within the first 7-10 days.It was just authorized on November 9th, and we’ll be getting out our first shipment in the next week or so.It may be able to reduce the need for hospitalization by 5-10%.</li><li>RemdesivirThis antiviral medication slows down the replication of the virus.Early studies showed that remdesivir reduced COVID-19 recovery times from 15 to 10 days.While initially only used in the late stages of COVID-19 illness, it’s now used as soon as a patient is found to need oxygen therapy.</li><li>This antiviral medication slows down the replication of the virus.</li><li>Early studies showed that remdesivir reduced COVID-19 recovery times from 15 to 10 days.</li><li>While initially only used in the late stages of COVID-19 illness, it’s now used as soon as a patient is found to need oxygen therapy.</li><li>DexamethasoneThis steroid medication is used to modulate your body’s inflammatory response against COVID-19.It has demonstrated a 35% decrease in mortality in patients on ventilators and a 20% decrease in patients requiring oxygen.It has not been shown to benefit patients who did not require oxygen.</li><li>This steroid medication is used to modulate your body’s inflammatory response against COVID-19.</li><li>It has demonstrated a 35% decrease in mortality in patients on ventilators and a 20% decrease in patients requiring oxygen.</li><li>It has not been shown to benefit patients who did not require oxygen.</li><li>Convalescent PlasmaThe FDA approved its use in August for patients with severe and life-threatening infections.It’s plasma from donors with prior COVID-19 infection which has antibodies to fight the coronavirus.&nbsp;</li><li>The FDA approved its use in August for patients with severe and life-threatening infections.</li><li>It’s plasma from donors with prior COVID-19 infection which has antibodies to fight the coronavirus.&nbsp;</li><li>Monoclonal AntibodiesThis lab-created antibody directly neutralizes the coronavirus to prevent progression of the disease.It’s typically given in outpatient settings to prevent a patient from becoming ill to the point of needing hospitalization.&nbsp; It’s given right after a patient tests positive, within the first 7-10 days.It was just authorized on November 9th, and we’ll be getting out our first shipment in the next week or so.It may be able to reduce the need for hospitalization by 5-10%.</li><li>This lab-created antibody directly neutralizes the coronavirus to prevent progression of the disease.</li><li>It’s typically given in outpatient settings to prevent a patient from becoming ill to the point of needing hospitalization.&nbsp; It’s given right after a patient tests positive, within the first 7-10 days.</li><li>It was just authorized on November 9th, and we’ll be getting out our first shipment in the next week or so.</li><li>It may be able to reduce the need for hospitalization by 5-10%.</li><li>Having your vitamin D in the normal range can also benefit you if you’re hospitalized with COVID-19. Vitamin D helps to regulate your inflammatory response.It’s beneficial to take vitamin D supplements now.The recommended dose of vitamin D is 400 international units (IUs). &nbsp;But most doctors recommend 4,000 to 5,000 IUs of vitamin D on a daily basis to get your levels built back up to normal.This is especially important in Nebraska during winter when there’s not as much sunlight.</li><li>Vitamin D helps to regulate your inflammatory response.</li><li>It’s beneficial to take vitamin D supplements now.</li><li>The recommended dose of vitamin D is 400 international units (IUs). &nbsp;But most doctors recommend 4,000 to 5,000 IUs of vitamin D on a daily basis to get your levels built back up to normal.</li><li>This is especially important in Nebraska during winter when there’s not as much sunlight.</li>
 </ul>Video from today’s press conference is available by&nbsp;<a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.dropbox.com%2Fs%2Fdl2vw6o99z6i20n%2FGov.%2520Press%2520Conf%252011.17.2020.mp4%3Fdl%3D0&amp;data=04%7C01%7Ccio.webmstr%40nebraska.gov%7C8658fc8a42a84e42a04208d88b51247c%7C043207dfe6894bf6902001038f11f0b1%7C0%7C0%7C637412527905796001%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=2IC%2FCB1OuI3QuWey3j%2Fw4uypHOncDOwLOhXD3NvL4IA%3D&amp;reserved=0" target="_blank">clicking here</a>.To see a chart of the restrictions in each colored phase of the State’s coronavirus response,&nbsp;<a href="https://gcc02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.dropbox.com%2Fs%2Fhmadcuih3j2xlyd%2FColor-Coded%2520%2520Phase%2520Comparison%252011.13.20.pdf%3Fdl%3D0&amp;data=04%7C01%7Ccio.webmstr%40nebraska.gov%7C8658fc8a42a84e42a04208d88b51247c%7C043207dfe6894bf6902001038f11f0b1%7C0%7C0%7C637412527905796001%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=XpI7uYy8muT6M1r62SNWznUP6ctJE50qXLn9wYHRadg%3D&amp;reserved=0" target="_blank">click here</a>.&nbsp;

Gov. Ricketts, Chief Medical Officer give overview of coronavirus treatments

LINCOLN, Neb. (AP) - Eleven more Nebraska prison employees have tested positive for the coronavirus this week, state officials said.

The Nebraska Department of Correctional Services said Monday that another eight prison staffers had tested positive for COVID-19. Four of them work at the Lincoln Correctional Center, three work at the Tecumseh State Correctional Institution and one staffer works at the Work Ethic Camp in McCook.

That followed a similar announcement Sunday that three other prison staff members had tested positive for the virus. Those workers are employed at the state Diagnostic and Evaluation Center, the Nebraska State Penitentiary in Lincoln and the Omaha Community Corrections Center.

All of the ill staff members are isolating themselves at home, and anyone who had close contact with them will be notified.

The department said a total of 263 corrections employees have now tested positive for the virus. Of those, 196 have recovered.

LINCOLN, Neb. (AP) - Eleven more Nebraska prison employees have tested positive for the coronavirus this week, state officials said.The Nebraska Department of Correctional Services said Monday that another eight prison staffers had tested positive for COVID-19. Four of them work at the Lincoln Correctional Center, three work at the Tecumseh State Correctional Institution and one staffer works at the Work Ethic Camp in McCook.That followed a similar announcement Sunday that three other prison staff members had tested positive for the virus. Those workers are employed at the state Diagnostic and Evaluation Center, the Nebraska State Penitentiary in Lincoln and the Omaha Community Corrections Center.All of the ill staff members are isolating themselves at home, and anyone who had close contact with them will be notified.The department said a total of 263 corrections employees have now tested positive for the virus. Of those, 196 have recovered.

11 more Nebraska prison employees test positive for virus

OMAHA, Neb. (AP) - The number of coronavirus cases in Nebraska topped 100,000 as the state reported a record 3,440 cases Monday.

Nebraska has had 101,601 cases of the virus since the pandemic began. There were also eighteen new deaths reported Monday to give the state 797 deaths.

The number of people hospitalized with the virus in the state set a new record at 938. Gov. Pete Ricketts has said if that number continues to rise and approaches 1,200 - when 25% of the hospitalized patients in the state have coronavirus - he will impose additional restrictions to limit the spread of the virus.

The number of people hospitalized with the virus has more than quadrupled since the start of October when 227 people were being treated for COVID-19, and hospitals are struggling to keep up with the caseload.

On Monday, Ricketts repeated his plea for residents to voluntarily avoid crowds and wear masks when around other people to stop the spread of the virus. But he once again said he won't impose a statewide mask mandate, even as a number of large and mid-sized cities have enacted their own. The city of Beatrice is moving forward with a new mandate, joining Omaha, Lincoln, Grand Island and Kearney.

"I don't think mask mandates are appropriate," Ricketts said in response to a question at a news conference. "I think they breed resistance."

He added that other states, such as Wisconsin, have enacted statewide mask mandates but have still seen a surge in cases. Many local public health officials have called for a mandate, saying it would have helped slow the increase in new cases and hospitalizations in Nebraska.

Nebraska has the sixth-highest rate of new virus cases in the nation. And over the past week, one out of every 120 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.

OMAHA, Neb. (AP) - The number of coronavirus cases in Nebraska topped 100,000 as the state reported a record 3,440 cases Monday.Nebraska has had 101,601 cases of the virus since the pandemic began. There were also eighteen new deaths reported Monday to give the state 797 deaths.The number of people hospitalized with the virus in the state set a new record at 938. Gov. Pete Ricketts has said if that number continues to rise and approaches 1,200 - when 25% of the hospitalized patients in the state have coronavirus - he will impose additional restrictions to limit the spread of the virus.The number of people hospitalized with the virus has more than quadrupled since the start of October when 227 people were being treated for COVID-19, and hospitals are struggling to keep up with the caseload.On Monday, Ricketts repeated his plea for residents to voluntarily avoid crowds and wear masks when around other people to stop the spread of the virus. But he once again said he won't impose a statewide mask mandate, even as a number of large and mid-sized cities have enacted their own. The city of Beatrice is moving forward with a new mandate, joining Omaha, Lincoln, Grand Island and Kearney."I don't think mask mandates are appropriate," Ricketts said in response to a question at a news conference. "I think they breed resistance."He added that other states, such as Wisconsin, have enacted statewide mask mandates but have still seen a surge in cases. Many local public health officials have called for a mandate, saying it would have helped slow the increase in new cases and hospitalizations in Nebraska.Nebraska has the sixth-highest rate of new virus cases in the nation. And over the past week, one out of every 120 people in the state was diagnosed with COVID-19, according to data from Johns Hopkins University.The seven-day rolling average of daily new cases in Nebraska has nearly doubled over the past two weeks from 1,124.14 new cases per day on Nov. 2 to 2,027.43 new cases per day on Nov. 16.

Coronavirus Update